2-(BROMOMETHYL)-3-(TRIFLUOROMETHYL)PYRIDINE HYDROBROMIDE, 95%, 100mg

5-methoxy-2-[(piperidin-4-yl)methoxy]pyrimidine hydrochloride, 1g

Sodium hydroxide, min. 99%, 1 kg, plastic packaging.

Methyl 4-(1-((tert-butoxycarbonyl)amino)cyclopropyl)benzoate, 97%, 100mg

(1S,2R)-1-((tert-Butoxycarbonyl)amino)-2-vinylcyclopropanecarboxylic acid, 97%, 10g

4-(3-Fluoro-phenyl)-1,3-thiazol-2-amine, 95.0%, 250mg

FLAVOXATE HYDROCHLORIDE, 95%, 5g

5-methyl-2,1,3-benzoxadiazole-4-sulfonyl chloride, 95.0%, 1g

Ethyl 7-fluoro-4-methoxy-1H-indole-2-carboxylate, 97.0%, 5g

DIMETHYL 1-BENZYL-1H-1,2,3-TRIAZOLE-4,5-DICARBOXYLATE, 95.0%, 500mg

2,4-Dichloro-8-fluoroquinazoline, 95.0%, 250mg

4-tert-Butyl 2-ethyl thiomorpholine-2,4-dicarboxylate, 95.0%, 250mg

GC capillary column ROTI®Cap-1, 60 m, 0.32 mm, 0.35 µm, 1 Piece(s)